Commonwealth Equity Services’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Commonwealth Equity Services’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-30,766	Closed	-$11K	–	3046
2020 Q1	$11K	Hold	30,766	–	–	﹤0.01%	2787
2019 Q4	$12K	Sell	30,766 -93,057	-75%	-$155K	﹤0.01%	2867
2019 Q3	$247K	Buy	123,823 +18,200	+17%	+$36.9K	﹤0.01%	2407
2019 Q2	$228K	Buy	105,623 +33,250	+46%	+$85K	﹤0.01%	2419
2019 Q1	$228K	Buy	72,373 +22,016	+44%	+$71.2K	﹤0.01%	2370
2018 Q4	$125K	Sell	50,357 -3,000	-6%	-$9.99K	﹤0.01%	2449
2018 Q3	$214K	Buy	53,357 +39,500	+285%	+$174K	﹤0.01%	2456
2018 Q2	$52K	Buy	+13,857	New	+$36.1K	﹤0.01%	2656

Commonwealth Equity Services's CORV Position: Q2 2020 in Review

Commonwealth Equity Services sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 30,766 shares — an estimated $11K sold.

Commonwealth Equity Services first reported a position in CORV in Q2 2018 and held it in 8 quarters. The position peaked at $247K in Q3 2019. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.

Commonwealth Equity Services reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
Commonwealth Equity Services sold 30,766 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $11K.
Commonwealth Equity Services first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2018 and held it in 8 quarters.
Commonwealth Equity Services's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $247K in Q3 2019.
0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.

Based on Commonwealth Equity Services's 13F filing for Q2 2020, filed 12 Aug 2020.